Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

LONDON (Reuters) -U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

This proves that Eli Lilly's obesity drug Zepbound, as a GLP-1/GIP agonist ... could benefit from any potential gains made here. In order for patients to be recruited into this specific study ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...

Pfizer (PFE), and Eli Lilly (LLY) traded in the green Monday morning despite declining in pre-market hours after President ...

The order aims to slash drug prices by up to 80%. Indian industry had been on edge since March amid threats of reciprocal ...